GLENMARK.NS · Glenmark Pharmaceuticals Limited
India · RS rating 60 · As of 2026-10-14
| Price | 2,246.00 INR |
|---|---|
| 1-day change | -0.8% |
| RS rating (overall / 1M / 3M / 12M) | 60 / 32 / 58 / 76 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 41 / 28 / 64 |
| Industry group (rank) | Pharma (32) |
| EPS growth Q/Q | +60.2% |
| Sales growth Q/Q | +4.6% |
| Distance from 52-week high | +10.7% |
| Market cap (USD) | $6.8B |